Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Components of the Earnings (Loss) per Common Share ) (Details)

v3.22.0.1
Earnings (Loss) Per Common Share (Components of the Earnings (Loss) per Common Share ) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Basic and diluted numerator:        
Net loss attributable to iBio, Inc. stockholders $ (11,920) $ (8,129) $ (20,859) $ (15,662)
Preferred stock dividends - iBio CMO Preferred Tracking Stock (22) (65) (88) (131)
Net loss available to iBio, Inc. stockholders $ (11,942) $ (8,194) $ (20,947) $ (15,793)
Basic and diluted denominator:        
Weighted-average common shares outstanding 217,990 188,087 217,933 175,264
Per share amount $ (0.05) $ (0.04) $ (0.10) $ (0.09)